BIO.News Newsletter

An FDA advisory panel recommends approval of Eli Lilly’s Alzheimer's drug donanemab, parents explain why we need to reauthorize the Rare Pediatric Disease Priority Review Voucher Program (PPRV), and we recap BIO 2024 sessions on women’s health. (611 words, 3 minutes, 3 seconds)

GSK’s RSV vaccine was approved for an expanded population, and a new study confirms an option for infants is effective. Plus, our BIO 2024 coverage is not over yet—and today, we get the patient perspective on PDABs and the IRA. (558 words, 2 minutes, 47 seconds)

We’re wrapping up a fantastic 2024 BIO International Convention with what FDA Commissioner Dr. Robert Califf said about supply chains (and more) and how you can get involved with ARPA-H—plus, a few headlines you might have missed. (703 words, 3 minutes, 30 seconds)

On Day 3 of the BIO International Convention, we learned about the National Security Commission on Emerging Biotechnology—more on that, plus a few takeaways on leadership and innovation. (729 words, 3 minutes, 38 seconds)

Day 2 of the BIO International Convention brought important conversations on biopharma's message in an election year, DEI, and how to grow the bioeconomy. Meanwhile, in Washington, D.C., lawmakers discussed 340B. (869 words, 4 minutes, 20 seconds)

We recap Day 1 of the BIO International Convention, including what we learned about government partnerships with industry for national security, Medicare Part D, and Alternative Funding Programs. (603 words, 3 minutes)

The 2024 BIO International Convention kicks off today in San Diego—and the Good Day BIO and Bio.News team is live on the ground, bringing you all the news and highlights. Here’s what we’re watching and how to follow—plus, details on Moderna’s RSV win and bills that would enhance national security through ag biotech. (718 words, 3 minutes, 35 seconds)

From avian flu to a potential new “smart” antibiotic, here’s what you need to know before the BIO International Convention—plus, Vermont’s Governor vetoed a bill that would have banned an important seed treatment. (600 words, 3 minutes)

The Inflation Reduction Act would discourage small molecule R&D—but lawmakers have proposed one “EPIC” solution. Plus, the potato finally has its day—and biotech is ensuring its longevity. (466 words, 2 minutes, 19 seconds)

A few more wins for biotech innovation: the CDC confirms the mpox vaccine is highly effective, and the FDA OKs an animal feed additive that will reduce methane emissions from cow belches. (457 words, 2 minutes, 17 seconds)